Fortress Biotech, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Fortress Biotech, Inc. filed an S-1 registration statement for the resale of 600,000 common shares underlying warrants issued to Oaktree affiliates in connection with a credit agreement amendment.
NASDAQ
Fortress Biotech is registering the resale of approximately 6.2 million shares of its common stock by existing selling stockholders, including shares issuable upon exercise of warrants.